Deltarasin hydrochloride is used to inhibit the interaction between KRAS and PDEδ, thereby suppressing the proliferation of human pancreatic ductal adenocarcinoma cells dependent on oncogenic KRAS; it also impairs tumor growth in nude mice bearing subcutaneous human Panc-Tu-I tumor cell xenografts.